Skip to main content
. 2016 Jul 7;8:ecurrents.outbreaks.06d10b6b4e690917d8b0a04268906143. [Version 1] doi: 10.1371/currents.outbreaks.06d10b6b4e690917d8b0a04268906143

Table 2. Trans-Isolate test results conducted on CSF samples collected from patients treated by MSF in Kebbi and Sokoto states, by location, February 16 to March 26, 2015.

*All 26 samples had PorA type P1.21-15,16. The 14 culture-positive isolates had genetic sequencing of ST-10217 PorA type P1.21-15,16 and FetA type F1-7. **PCR stands for Real-time polymerase chain reaction.

Kebbi State Sokoto State Total
All Trans-Isolate Tests (Culture and PCR**)
Total number of CSF samples tested 18 13 31
Total number of positive NmC samples (%) 14 (78%) 12 (92%) 26* (84%)
Culture
Number of CSF samples tested 8 6 14
Number of positive NmC samples (%) 8 (100%) 6 (100%) 14 (100%)
PCR
Number of CSF samples tested 10 7 17
Number of positive NmC samples (%) 6 (60%) 6 (86%) 21 (71%)